Tappy L, Chioléro R, Berger M
Institute of Physiology, University of Lausanne, Switzerland.
Curr Opin Clin Nutr Metab Care. 1999 Mar;2(2):161-4. doi: 10.1097/00075197-199903000-00012.
Plasma glucose concentration is a major regulator of glucose production in experimental animals and in humans. Hyperglycemia inhibits and hypoglycemia stimulates glucose production through mechanisms which are, in part, independent of changes in glucoregulatory hormones. Glucose production does not change when gluconeogenesis is acutely inhibited or stimulated. These observations indicate an autoregulatory process by which hepatic glucose production is altered as a direct consequence of changes in glycemia. Data obtained in patients with glucokinase gene mutations indicate that glucokinase may play a role in this regulatory process. Hyperglycemia in type 2 diabetic patients and in critically ill patients may result from a blunted effect of hyperglycemia on glucose production.
血浆葡萄糖浓度是实验动物和人类葡萄糖生成的主要调节因子。高血糖通过部分独立于葡萄糖调节激素变化的机制抑制葡萄糖生成,而低血糖则刺激葡萄糖生成。当糖异生被急性抑制或刺激时,葡萄糖生成不会改变。这些观察结果表明存在一种自动调节过程,通过该过程,肝脏葡萄糖生成作为血糖变化的直接后果而改变。在葡萄糖激酶基因突变患者中获得的数据表明,葡萄糖激酶可能在这一调节过程中发挥作用。2型糖尿病患者和重症患者的高血糖可能是由于高血糖对葡萄糖生成的作用减弱所致。